Compare Globus Medical Inc. Class A Common Stock (GMED) vs Main Street Capital Corporation (MAIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Main Street Capital Corporation — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Main Street Capital Corporation trades at $53.66 (market cap $5.03B). The key difference: Globus Medical Inc. Class A Common Stock is far larger — about 2× Main Street Capital Corporation's market cap, and Main Street Capital Corporation pays a 5.91% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Main Street Capital Corporation for 89 Days on average.
| GMED | MAIN | |
|---|---|---|
Market Cap | $10.25B | $5.03B |
Volume | 1,108,124 | 386,945 |
Sector | Health | Financials |
52-Week High | $96.82 | $64.60 |
52-Week Low | $58.33 | $49.63 |
Typical Hold Time | 0 Days | 89 Days |
Enterprise Value | $9.76B | $7.48B |
Dividend Yield | — | 5.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
MAIN trades at $53.50, down 0.3% on the day, with a bearish technical signal and key support at $53. The stock shows strong profitability with an 80.77% net margin and a P/E of 10.8, but revenue declined slightly in 2025 to $592M. Recent quarterly earnings have been mixed, beating in Q2 2026 but missing in Q1. The company maintains a consistent dividend, with recent payments of $0.27-$0.30 per share.
The outlook is cautious; while MAIN's high margins and dividend yield near 7.9% appeal to income investors, bearish technicals, softening revenue, and a high proportion of analyst 'Hold' ratings suggest limited near-term upside. Risks include earnings volatility and sensitivity to interest rates, but the stock trades below the consensus price target of $58, offering potential appreciation if fundamentals stabilize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →
